Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 615-712-2 | CAS number: 720-94-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 8 July 2014 - 4 September 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test method according to OECD Guideline 438. GLP study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.48 (Isolated chicken eye test method for identifying occular corrosives and severe irritants)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 4,4,4-trifluoro-1-(4-methylphenyl)butane-1,3-dione
- EC Number:
- 615-712-2
- Cas Number:
- 720-94-5
- Molecular formula:
- C11H9F3O2
- IUPAC Name:
- 4,4,4-trifluoro-1-(4-methylphenyl)butane-1,3-dione
- Details on test material:
- - Name of test material: 4,4,4-Trifluoro-1-(4-methylphenyl)-1,3-butanedione
- Physical state: slightly coloured crystalline powder
- Analytical purity: 99.9%
- Lot/batch No.: M13696C
Constituent 1
Test animals / tissue source
- Species:
- other: chicken
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Zakład Przemysłu Drobiarskiego JAS-DROP in Krzyżowice
- Age at study initiation: 7-week-old
- Weight at study initiation: 1.5 - 2.5 kg
BIOLOGICAL MATERIAL
After sedation of the chickens by electric shock and incision of the neck for bleeding, their heads were transported to the laboratory in a plastic container at ambient temperature. During the transport, the heads were humidified with a physiological salt solution by placing moistened paper towels inside the container. The time interval between the collection of the chickens’ heads and the use of their eyeballs in the ICE test was 30 minutes.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.03 g
Application and removal of the test item and the control items:
There were three groups, i.e. one group treated with the test item and two control groups, including a positive one (imidazole) and a negative one (physiological salt) used concurrently in the study to ensure its quality. The test item and the control items were tested on three eyeballs each. Immediately following the zero reference measurements, the eyeballs in their holders were removed from the superfusion apparatus and placed in a horizontal position in order to apply the test item and the control items. The test item (ground to a powder) and the item used in the positive control (imidazole) were applied in the amount of 0.03 g, whereas the item used in the negative control (physiological salt) was applied in a volume of 0.03 mL. The test item and the control items were uniformly applied to the corneal surface for 10 seconds. Then, they were rinsed from the eye with 20 mL of physiological salt at ambient temperature. - Duration of treatment / exposure:
- 10 seconds
- Observation period (in vivo):
- 4 hours after post-treatment rinse.
- Number of animals or in vitro replicates:
- 9 eyeballs (3 eyeballs per treatment: test item, negative control, positive control).
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): Yes (physiological salt)
- Time after start of exposure: After 10 seconds of exposure.
MEASURED PARAMETERS:
Pretreatment and starting at 30, 75, 120, 180, and 240 minutes (± 5 minutes) after the post-treatment rinse.
At all observation times points, corneal opacity and swelling were evaluated, whereas morphological changes of the corneal surface were recorded. The quantitative determination of fluorescein retention was performed only once, i.e. 30 minutes after the end of the exposure.
Scoring system
Fluorescein retention:
0 No fluorescein retention
0.5 Very minor single cell staining
1 Single cell staining scattered throughout the treated area of the cornea
2 Focal or confluent dense single cell staining
3 Confluent large areas of the cornea retaining fluorescein
Corneal opacity:
0 No opacity
0.5 Very faint opacity
1 Scattered or diffuse areas; details of the iris are clearly visible
2 Easily discernible translucent areas; details of the iris are slightly obscured
3 Severe corneal opacity; no specific details of the iris are visible; size of the pupil is barely discernible
4 Complete corneal opacity; iris invisible
Corneal swelling:
The degree of corneal swelling was determined by measuring corneal thickness with a SP-100 pachymeter.
Gross evaluation:
To determine whether any morphological effects, e.g. pitting of corneal epithelial cells, roughening of the corneal surface, and sticking of the test item to the cornea were visible.
Histopathological evaluation of the treated corneas:
Following the final evaluation of the treated eyeballs (240 minutes after the application of the test item and the control items), the eyeballs were fixed in a 4% solution of formaldehyde. Next, specimens were collected (one specimen in the plane including the cornea, lens, and optic nerve). The tissue material was dehydrated and prepared using a paraffin technique. Paraffin blocks were cut into smaller parts, whose thickness was 5 μm, with a microtome and stained using Hematoxylin and Eosin. The following layers of the cornea were evaluated: anterior epithelium, anterior elastic lamina (Bowman’s membrane), corneal stroma, posterior elastic lamina (Descemet’s membrane), and posterior epithelium. All treated eyeballs were subject to this evaluation.
Results and discussion
In vivo
- Irritant / corrosive response data:
- On the grounds of the study and the overall in vitro Irritancy Classification, it may be stated that the test item can cause eye damage. According to UN GHS classification criteria, the test item can be classified to Category 1, since the ICE Class combination of the 3 endpoints was 3xIV (the first run); 2xIV and 1xIII (the second run).
Any other information on results incl. tables
Evaluation of fluorescein retention– the first run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
3.0 |
IV |
3.0 |
IV |
0.0 |
I |
Evaluation of fluorescein retention – the second run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
2.7 |
IV |
3.0 |
IV |
0.0 |
I |
Evaluation of corneal opacity– the first run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
75 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
120 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
180 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
240 |
3.0 |
IV |
4.0 |
IV |
0.0 |
I |
Evaluation of corneal opacity – the second run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
2.7 |
IV |
4.0 |
IV |
0.0 |
I |
75 |
2.7 |
IV |
4.0 |
IV |
0.0 |
I |
120 |
2.7 |
IV |
4.0 |
IV |
0.0 |
I |
180 |
2.7 |
IV |
4.0 |
IV |
0.0 |
I |
240 |
2.7 |
IV |
4.0 |
IV |
0.0 |
I |
Evaluation of corneal swelling (%)– the first run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
9.0 |
II |
24.1 |
III |
2.4* |
I |
75 |
11.8 |
II |
32.5 |
IV |
4.6* |
I |
120 |
20.0 |
III |
35.4 |
IV |
8.0* |
I |
180 |
27.6 |
III |
40.3 |
IV |
9.6* |
I |
240 |
32.6 |
IV |
44.5 |
IV |
11.7* |
I |
* - percentage of corneal thickness decrease, no swelling
Evaluation of corneal swelling (%) – the second run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
|||
Average |
ICE class |
Average |
ICE class |
Average |
ICE class |
|
30 |
3.3 |
I |
22.9 |
III |
0.7* |
I |
75 |
5.8 |
II |
31.4 |
IV |
1.9* |
I |
120 |
8.9 |
II |
49.6 |
IV |
3.7* |
I |
180 |
22.6 |
III |
51.8 |
IV |
4.4* |
I |
240 |
25.5 |
III |
53.7 |
IV |
5.4* |
I |
* - percentage of corneal thickness decrease, no swelling
Gross evaluation of the treated corneas - the first run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
||||||
Eyeball no. |
Eyeball no. |
Eyeball no. |
|||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
30 |
SIGNS |
SINGS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
75 |
SINGS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
120 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
180 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
240 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
NC = no changes
SIGNS = roughening of the corneal surface
Gross evaluation of the treated corneas - the second run.
Observation after (minutes) |
Test item |
Positive control Imidazole |
Negative control Physiological saline |
||||||
Eyeball no. |
Eyeball no. |
Eyeball no. |
|||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|
30 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
75 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
120 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
180 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
240 |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
SIGNS |
NC |
NC |
NC |
NC = no changes
SIGNS = roughening of the corneal surface
Histological examination of the corneas treated with the test item - the first run.
The corneas treated with the test item showed lack of the anterior corneal epithelium (eyeball no. 1 and no. 2); lack of the posterior corneal epithelium (eyeball no. 1); detachment of the posterior corneal epithelium (eyeball no. 2); exfoliation, dissection and defects of the anterior corneal epithelium (eyeball no. 3).
Histopathological examination of the corneas treated with the test item - the second run.
The corneas treated with the test item showed lack of the anterior corneal epithelium (eyeball no. 1); exfoliation of the anterior corneal epithelium (eyeballs no. 2, and no. 3); dissection of the anterior corneal epithelium (eyeball no. 3) and dissection of the corneal stroma (eyeball no. 3).
Applicant's summary and conclusion
- Interpretation of results:
- Category I
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
- Conclusions:
- On the grounds of the study and the overall in vitro Irritancy Classification, it may be stated that the test item can cause eye damage.
- Executive summary:
The isolated chicken eye test (in vitro) was performed according to OECD Guideline 438 and EU Method B.48 (GLP study). The study was conducted in two runs. The first study led to a GHS Category I outcome, so a second run of nine eyeballs was conducted to confirm or discard the positive outcome. The test item (ground to a powder) and the item used in the positive control (imidazole) were applied in the amount of 0.03 g, whereas the item used in the negative control (physiological salt) was applied in a volume of 0.03 mL. Three eyeballs were used for the test item and three for each control item. Every time, the test item and the control items were applied to the corneal surface for 10 seconds and kept at temperature between 20 – 23º C. Then, they were rinsed from the eye with 20 mL of physiological salt at ambient temperature. The corneas were evaluated pretreatment and starting at 30, 75, 120, 180, and 240 minutes (± 5 minutes) after the post-treatment rinse. At all observation time points, corneal opacity and swelling were evaluated, whereas morphological changes of the corneal surface were recorded. The quantitative determination of fluorescein retention was performed only once, i.e. 30 minutes after the end of the exposure. Following the final evaluation of the treated eyeballs, i.e. 240 minutes after the application of the test item and the control items, the eyeballs were fixed in a 4% solution of formaldehyde in order to allow histopathological examinations to be conducted. The test item can cause eye damage. The obtain mean fluorescein retention scores for the eyeball treated with test item were 3.0 (ICE class IV) and 2.7 (ICE class IV) in the first and second round respectively. The mean corneal opacity scores were 3.0 (ICE class IV) and 2.7 (ICE class IV). The mean corneal swelling value for the eyeballs treated with the test item were from 9.0 (II ICE class) to 32.6 (IV ICE class) in the first run and from 3.3 (I ICE class) to 25.5 (III ICE class) in the second run. Gross examinations of the eyeballs treated with the test item revealed roughening of the corneal surface in both runs. Histopathological examinations of the corneas treated with the test item showed lack of the anterior corneal epithelium; lack of the posterior corneal epithelium; detachment of the posterior corneal epithelium; and exfoliation, dissection and defects of the anterior corneal epithelium in both runs. On the grounds of the study results and the overall in vitro Irritancy Classification, it may be stated that the test item can cause eye damage. According to UN GHS classification criteria, no prediction can be made, since the ICE Class combination of the 3 endpoints was 3xIV (the first run); 2xIV and 1xIII (the second run).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
